Advisors Asset Management Inc. trimmed its holdings in Keurig Dr Pepper, Inc (NASDAQ:KDP - Free Report) by 47.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 36,537 shares of the company's stock after selling 33,314 shares during the period. Advisors Asset Management Inc.'s holdings in Keurig Dr Pepper were worth $1,250,000 as of its most recent SEC filing.
A number of other institutional investors also recently made changes to their positions in KDP. Cary Street Partners Financial LLC acquired a new position in shares of Keurig Dr Pepper in the 4th quarter valued at approximately $77,000. Captrust Financial Advisors raised its position in shares of Keurig Dr Pepper by 26.4% during the 4th quarter. Captrust Financial Advisors now owns 69,463 shares of the company's stock valued at $2,231,000 after acquiring an additional 14,522 shares in the last quarter. EP Wealth Advisors LLC acquired a new stake in shares of Keurig Dr Pepper during the 4th quarter valued at approximately $248,000. Focus Partners Wealth grew its stake in Keurig Dr Pepper by 225.7% during the 4th quarter. Focus Partners Wealth now owns 61,215 shares of the company's stock worth $1,967,000 after buying an additional 42,420 shares during the last quarter. Finally, Janus Henderson Group PLC grew its stake in Keurig Dr Pepper by 1.7% during the 4th quarter. Janus Henderson Group PLC now owns 157,359 shares of the company's stock worth $5,055,000 after buying an additional 2,579 shares during the last quarter. 93.99% of the stock is owned by institutional investors and hedge funds.
Insider Activity
In related news, insider Mary Beth Denooyer sold 12,000 shares of the stock in a transaction dated Thursday, July 17th. The stock was sold at an average price of $33.66, for a total value of $403,920.00. Following the completion of the sale, the insider directly owned 82,511 shares of the company's stock, valued at approximately $2,777,320.26. This represents a 12.70% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Robert James Gamgort sold 7,601 shares of the firm's stock in a transaction dated Wednesday, August 20th. The stock was sold at an average price of $35.91, for a total value of $272,951.91. Following the sale, the director directly owned 2,284,568 shares of the company's stock, valued at $82,038,836.88. This trade represents a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders sold 459,601 shares of company stock valued at $15,228,872. Company insiders own 0.40% of the company's stock.
Keurig Dr Pepper Trading Down 1.2%
Shares of NASDAQ:KDP traded down $0.33 during midday trading on Friday, reaching $27.27. The company had a trading volume of 10,170,124 shares, compared to its average volume of 13,240,169. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.40 and a current ratio of 0.64. Keurig Dr Pepper, Inc has a 1-year low of $27.01 and a 1-year high of $38.28. The firm has a market cap of $37.04 billion, a price-to-earnings ratio of 24.34, a price-to-earnings-growth ratio of 1.50 and a beta of 0.47. The company has a fifty day simple moving average of $32.47 and a two-hundred day simple moving average of $33.32.
Keurig Dr Pepper (NASDAQ:KDP - Get Free Report) last announced its quarterly earnings data on Thursday, July 24th. The company reported $0.49 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.49. The firm had revenue of $4.16 billion during the quarter, compared to the consensus estimate of $4.14 billion. Keurig Dr Pepper had a return on equity of 11.05% and a net margin of 9.75%.The business's revenue for the quarter was up 6.1% on a year-over-year basis. During the same period in the prior year, the business earned $0.45 EPS. Research analysts predict that Keurig Dr Pepper, Inc will post 1.92 earnings per share for the current year.
Analyst Ratings Changes
A number of research analysts recently commented on the company. UBS Group lowered their price objective on Keurig Dr Pepper from $40.00 to $35.00 and set a "buy" rating for the company in a research note on Wednesday, August 27th. JPMorgan Chase & Co. lowered their price objective on Keurig Dr Pepper from $39.00 to $38.00 and set an "overweight" rating for the company in a research note on Thursday, July 17th. HSBC restated a "hold" rating and set a $30.00 price objective (down from $42.00) on shares of Keurig Dr Pepper in a research note on Tuesday, August 26th. Jefferies Financial Group set a $41.00 price objective on Keurig Dr Pepper in a research note on Monday, August 25th. Finally, Deutsche Bank Aktiengesellschaft lowered their price objective on Keurig Dr Pepper from $40.00 to $38.00 and set a "buy" rating for the company in a research note on Tuesday, August 26th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to MarketBeat.com, Keurig Dr Pepper has a consensus rating of "Moderate Buy" and a consensus price target of $38.38.
Check Out Our Latest Research Report on KDP
Keurig Dr Pepper Company Profile
(
Free Report)
Keurig Dr Pepper Inc owns, manufactures, and distributors beverages and single serve brewing systems in the United States and internationally. It operates through three segments: U.S. Refreshment Beverages, U.S. Coffee, and International. The U.S. Refreshment Beverages segment manufactures and distributes branded concentrates, syrup, and finished beverages.
Featured Articles

Before you consider Keurig Dr Pepper, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Keurig Dr Pepper wasn't on the list.
While Keurig Dr Pepper currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.